FindTrial
Sign In

Compassionate Use of Evinacumab

Status
APPROVED_FOR_MARKETING
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT06500598
Enrollment
Unknown
Registered
2024-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Homozygous Familial Hypercholesterolemia (HoFH), Severe Hypertriglyceridemia (HTG), Dysbetalipoproteinemia (DBL)

Brief summary

Provide compassionate use of evinacumab

Detailed description

Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications. Availability will depend on location.

Interventions

DRUGEvinacumab

Sponsors

Regeneron Pharmaceuticals
Lead SponsorINDUSTRY

Eligibility

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026